Effects of the Drug Treatment for Osteoporosis in Clinical Settings, Monotherapy or Concurrent Therapy
Author:
- 1 December 2021
- book chapter
- Published by Springer Nature
- p. 431-440
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Goal-directed treatment of osteoporosisJournal of Bone and Mineral Research, 2013
- Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) – 02Current Medical Research and Opinion, 2011
- Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fracturesJournal of Bone and Mineral Metabolism, 2010
- Vitamin D sufficiency is associated with low incidence of limb and vertebral fractures in community-dwelling elderly Japanese women: the Muramatsu StudyOsteoporosis International, 2010
- Clinical Value of Monitoring BMD in Patients Treated With Bisphosphonates for OsteoporosisJournal of Bone and Mineral Research, 2009
- European guidance for the diagnosis and management of osteoporosis in postmenopausal womenOsteoporosis International, 2008
- Osteoporosis Prevention, Diagnosis, and TherapyJAMA, 2001
- Health-Related Quality of Life in Postmenopausal Women With Low BMD With or Without Prevalent Vertebral FracturesJournal of Bone and Mineral Research, 2000
- Study Subjects and Ordinary PatientsOsteoporosis International, 2000
- Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral FracturesResults From the Fracture Intervention TrialJAMA, 1998